Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-04-21FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) from H2-Pharma LLC, authorizing changes to its regulatory …
-
FDA approval · 2020-04-14FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc., likely updating or expanding…
-
FDA approval · 2020-04-14FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for VERSACLOZ (clozapine) filed by TruPharma LLC. Clozapine is an antipsychotic indicated for sc…
-
FDA approval · 2020-04-06FDA Approved: PERPHENAZINE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original ANDA for Perphenazine by Zydus Pharmaceuticals (USA) Inc., enabling the manufacture and distribution of a generic …
-
FDA approval · 2020-03-11FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for ziprasidone hydrochloride under an ANDA. This action supports a generic version of …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-02-20FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr.Reddys Laboratories Inc)
The FDA approved a supplemental application for aripiprazole from Dr. Reddy's Laboratories Inc., supporting regulatory action for the generi…
-
FDA approval · 2020-02-06FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' supplemental abbreviated new drug application for aripiprazole, granting approval of a generic version.
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride submitted by Upsher-Smith Laboratories, LLC.
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, Inc., signaling an approved mod…
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-Tab (risperidone) from Janssen Pharmaceuticals.
-
FDA approval · 2020-02-05FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Risperdal (risperidone) from Janssen Pharmaceuticals, Inc. The action updates the product la…
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Chlorpromazine Hydrochloride from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approves a supplemental application for ARIPIPRAZOLE (Aripiprazole) from Lannett Company, expanding approval of a generic antipsycho…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.’s supplemental application for aripiprazole (generic aripiprazole), authorizing the sale of a generic version of t…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's supplemental application to manufacture and market aripiprazole orally disintegrating tablets as a generic product.
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride (Upsher-Smith Laboratories, LLC), confirming continued approval of …
-
FDA approval · 2020-02-05FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for ABILIFY MAINTENA (aripiprazole long-acting injectable) from Otsuka America Pharmaceutical, I…
-
FDA approval · 2020-02-05FDA Approved: PERSERIS — Supplemental Application (Indivior Inc.)
FDA approved a supplemental application for PERSERIS (risperidone) submitted by Indivior Inc.
-
FDA approval · 2020-02-05FDA Approved: CHLORPROMAZINE HCI — Supplemental Application (Dr. Reddy's Laboratories Inc.,)
FDA approved a supplemental application for chlorpromazine HCl from Dr. Reddy's Laboratories, confirming the generic product's approval unde…
-
FDA approval · 2020-02-05FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approves a supplemental application for a generic version of aripiprazole from Alembic Pharmaceuticals Inc.
-
FDA approval · 2020-02-04FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application to market a generic ARIPIPRAZOLE under an ANDA.
-
FDA approval · 2020-02-04FDA Approved: ARIPIPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ARIPIPRAZOLE from Aurobindo Pharma Limited, indicating regulatory clearance for changes to the a…
-
FDA approval · 2020-01-27FDA Approved: ILOPERIDONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for iloperidone by Mylan Pharmaceuticals Inc., indicating a new or expanded approval for the gen…
-
FDA approval · 2020-01-27FDA Approved: QUETIAPINE EXTENDED RELEASE — Supplemental Application (ACI Healthcare USA, Inc.)
FDA approved a supplemental application for Quetiapine Extended Release, enabling the generic product by ACI Healthcare USA, Inc. to be mark…
-
FDA approval · 2020-01-23FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.